RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 11 - per page Next page
Order by
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Seeking new technologies and/or existing products More
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases. More
Invar is a Russian based pharmaceutical company with proven sales and marketing capabilities around the local area. Partner with Invar to promote your products into and around Russia. More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Displaying 1..10 of 11 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Dec 2010 - 37 pages - $5,700
Dec 2010 - 58 pages - $5,700
Jun 2010 - 48 pages - $5,700
Dec 2010 - 55 pages - $5,700
Jun 2010 - 68 pages - $5,700
Nov 2010 - 111 pages - $5,700
Apr 2011 - 58 pages - $3,800

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us